We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+1.2%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$38.6B
AUM Growth
+$669M
(+1.8%)
Cap. Flow
+$1.61B
Cap. Flow
% of AUM
4.18%
Top 10 Holdings %
Top 10 Hldgs %
13.49%
Holding
2,814
New
394
Increased
941
Reduced
1,071
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$550M |
| 2 |
Eli Lilly
LLY
|
+$493M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$418M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$381M |
| 5 |
Meta Platforms (Facebook)
META
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$486M |
| 2 |
Pfizer
PFE
|
+$433M |
| 3 |
Apple
AAPL
|
+$430M |
| 4 |
Tesla
TSLA
|
+$401M |
| 5 |
Roku
ROKU
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.02% |
| 2 | Healthcare | 23.8% |
| 3 | Communication Services | 9.19% |
| 4 | Financials | 8.73% |
| 5 | Consumer Discretionary | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Nature's Sunshine
NATR
$354M
| $1.08M | ﹤0.01% |
73,500
-23,100
| -24% | -$388K |
|
|
SPPI
1577
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.08M | ﹤0.01% |
493,991
-1,011,300
| -67% | -$2.76M |
|
|
VOLT
1578
DELISTED
Volt Information Sciences, Inc.
VOLT
| $1.08M | ﹤0.01% |
303,000
+34,400
| +13% | +$150K |
|
1579
CRA International
CRAI
$1.16B
| $1.07M | ﹤0.01% |
10,791
-1,800
| -14% | -$162K |
|
|
PGRE
1580
DELISTED
Paramount Group
PGRE
| $1.07M | ﹤0.01% |
119,100
+5,000
| +4% | +$46.3K |
|
1581
Inseego
INSG
$114M
| $1.07M | ﹤0.01% |
16,050
+14,170
| +754% | +$1.18M |
|
1582
TETRA Technologies
TTI
$1.14B
| $1.07M | ﹤0.01% |
342,756
-448,200
| -57% | -$1.44M |
|
1583
American Vanguard Corp
AVD
$68.4M
| $1.07M | ﹤0.01% |
70,900
+60,700
| +595% | +$960K |
|
1584
CNB Financial Corp
CCNE
$1.04B
| $1.07M | ﹤0.01% |
43,837
+4,700
| +12% | +$113K |
|
1585
SFL Corp
SFL
$1.64B
| $1.07M | ﹤0.01% |
127,345
+68,677
| +117% | +$520K |
|
1586
Clear Channel Outdoor Holdings
CCO
$1.23B
| $1.07M | ﹤0.01% |
393,215
+52,400
| +15% | +$131K |
|
1587
Copa Holdings
CPA
$5.76B
| $1.07M | ﹤0.01% |
13,100
-11,900
| -48% | -$890K |
|
1588
Innovative Industrial Properties
IIPR
$1.71B
| $1.06M | ﹤0.01% |
4,603
-4,777
| -51% | -$1.08M |
|
1589
Cabot Corp
CBT
$4.54B
| $1.06M | ﹤0.01% |
21,200
-20,122
| -49% | -$1.08M |
|
1590
Enliven Therapeutics
ELVN
$3.92B
| $1.06M | ﹤0.01% |
+65,150
| New | +$1.35M |
|
1591
Standard BioTools
LAB
$340M
| $1.06M | ﹤0.01% |
161,188
-25,200
| -14% | -$166K |
|
|
MRCC
1592
DELISTED
Monroe Capital Corp
MRCC
| $1.06M | ﹤0.01% |
101,900
-35,800
| -26% | -$386K |
|
1593
Veru
VERU
$36M
| $1.06M | ﹤0.01% |
12,420
+5,610
| +82% | +$445K |
|
1594
Precision BioSciences
DTIL
$180M
| $1.05M | ﹤0.01% |
3,047
+1,560
| +105% | +$529K |
|
|
SFE
1595
DELISTED
Safeguard Scientifics, Inc.
SFE
| $1.05M | ﹤0.01% |
118,733
+71,500
| +151% | +$573K |
|
|
TVRD
1596
Tvardi Therapeutics
TVRD
$19.7M
| $1.05M | ﹤0.01% |
1,892
-5,483
| -74% | -$2.75M |
|
1597
GXO Logistics
GXO
$5.77B
| $1.05M | ﹤0.01% |
+13,400
| New | +$1.05M |
|
|
CDTX
1598
DELISTED
Cidara Therapeutics
CDTX
| $1.05M | ﹤0.01% |
23,430
+21,400
| +1,054% | +$813K |
|
1599
National CineMedia
NCMI
$376M
| $1.05M | ﹤0.01% |
29,402
-19,220
| -40% | -$624K |
|
1600
Akebia Therapeutics
AKBA
$354M
| $1.04M | ﹤0.01% |
362,892
+3,500
| +1% | +$9.99K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, Two Sigma Advisers held 2,814 positions worth $38.6B, up 1.8% from $37.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers deployed $1.61B of net new capital in Q3 2021, opening 394 new positions and adding to 941 existing holdings. Its largest new stake was Danaher: 1,248,470 shares worth $337M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $486M trimmed.
- Two Sigma Advisers's largest Q3 2021 buy was Danaher: 1,248,470 shares worth $337M.
- Two Sigma Advisers added most to Microsoft in Q3 2021, an estimated $550M increase.
- Two Sigma Advisers's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $486M.
- Two Sigma Advisers fully exited Roku in Q3 2021, selling an estimated $374M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $38.6B portfolio in Q3 2021.
- Two Sigma Advisers opened 394 new positions and closed 396 in Q3 2021.
- Two Sigma Advisers's portfolio value rose 1.8% quarter-over-quarter to $38.6B.
Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.